Males with 17β-hydroxysteroid dehydrogenase deficiency

Endocrinologist

Volumn 13, Issue 3, 2003, Pages 195-200

  Simard, Jacques ^a   Moisan, Anne Marie ^a   Michel, Laurence Calemard ^b   Morel, Yves ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; ENZYME DEFICIENCY; GENE MUTATION; HORMONE SUBSTITUTION; HUMAN; MALE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; TESTOSTERONE 17BETA DEHYDROGENASE DEFICIENCY; TESTOSTERONE SYNTHESIS;

EID: 0038266943     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000081674.43801.0b     Document Type: Conference Paper

References (34)

1. Labrie F, Luu-The V, Lin SX, et al.: Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000;25:1-16.
2. Peltoketo H, Luu-The V, Simard J, et al.: 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 1999;23:1-11.
3. Geissler WM, Davis DL, Wu L, et al.: Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet 1994;7:34-9.
4. van Grunsven EG, van Berkel E, Ijlst L, et al.: Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci USA 1998;95:2128-33.
5. Lin HK, Jez JM, Schlegel BP, et al.: Expression and characterization of recombinant type 2 3 α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3-α / 17β-HSD activity and cellular distribution [published erratum appears in Mol Endocrinol 1999;12:1763]. Mol Endocrinol 1997;11:1971-84.
6. Dufort I, Rheault P, Huang XF, et al.: Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 1999;140:568-74.
7. El-Alfy M, Lu-The V, Huang XF, et al.: Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 1999;140:1481-91.
8. Biswas MG: Expression cloning and characterization of oxidative 17β-and 3α-hydroxysteroid dehydrogenase from rat and human prostate. J Biol Chem 1997:15959-66.
9. Krazeisen A, Breitling R, Imai K, et al.: Determination of cDNA, gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7(1). FEBS Lett 1999;460: 373-9.
10. Fomitcheva J, Baker ME, Anderson E, et al.: Characterization of Ke 6, a new 17β-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. J Biol Chem 1998;273:22664-71.
11. Forest MG: Diagnosis and treatment of disorders of sexual development. In Degroot LJ, ed. Endocrinology. Montreal: WB Saunders; 1995:1901-37.
12. Peretti D, Saez J, Bertrand J: Familial male pseudohermaphroditism (MPH) due to 17-ketosteroid reductase defect: in vitro study and testicular incubation. Excerpta Medica International Congress Series no 210. 1970. Amsterdam.
13. Saez JM, et al.: Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 1971;32:604-10.
14. Saez JM, Frederich A, Bertrand J: Further in vivo studies in male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect (compared to a case of testicular feminization). J Clin Endocrinol Metab 1972;34:598-600.
15. Grumbach M, Conte F: Disorders of sex differentitiation. In Wilson JD, ed. Williams Texbook of Endocrinology. Philadelphia, PA: W.B. Saunders, 1999:1303-425.
16. Simard J: Molecular genetics of 17β-hydroxysteroid dehydrogenase deficiency. In Mason I, ed. Genetics of Steroid Biosynthesis and Function, Modern Genetics. New York, NY: Harwood Academic Publishers; 2001.
17. Andersson S, Geissler WM, Wu L, et al.: Molecular genetics and pathophysiology of 17β-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996;81:130-6.
18. Rosler A, Belanger A, Labrie F: Mechanisms of androgen production in male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1992;75:773-8.
19. Wilson SC, Hodgins MB, Scott JS: Incomplete masculinization due to a deficiency of 17β-hydroxysteroid dehydrogenase: comparison of prepubertal and peripubertal siblings. Clin Endocrinol (Oxf) 1987; 26:459-69.
20. Pang SY, Softness B, Sweeney WJ, et al.: Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N Engl J Med 1987;316:1295-301.
21. Toscano V, Balducci R, Bianchi P, et al.: Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. J Clin Endocrinol Metab 1990;71:288-92.
22. Rosler A, Silverstein S, Abeliovich D: A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996;81:1827-31.
23. Mendonca BB, Boehmer AL, Brinkmann AO, et al.: 17β-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999;84:802-4.
24. Zhang Y, Word RA, Fesmire S, et al.: Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2 and 3. J Clin Endocrinol 1996;81:3594-8.
25. Luu-The V, Dufort I, Pelletier G: Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol 2001;171:77-82.
26. Morel Y, et al.: Etiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2001;161:49-59.
27. Boehmer AL, Brinkmann AO, Sandkuijl LA, et al.: 17β-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999;84:4713-21.
28. Moghrabi N, Zeitoun K, Takayama K, et al: Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17B3). J Clin Endocrinol Metab 1998;83:2855-60.
29. Bilbao JR, Loridan L, Audi L, et al: A novel missense (R80W) mutation in 17β-ydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur J Endocrinol 1998;139:330-3.
30. David M, Forrest MG, Mollard P, et al.: Difficulties in the diagnosis of 17β-hydroxysteroid dehydrogenase deficiency. Mimicking the androgen insensitivity syndrome (AIS) in early infancy. Arch French Pediatr 1990;47:107-13.
31. Calemard-Michel L, et al.: Le deficit en 17-ceto-reductase est bien du a des mutations du gene 17β-Hydroxysteroide deshydrogenase type 3: Etude de 8 familles. Ann Endocrinol 1996;57:357.
32. Calemard-Michel L, et al.: Pitfalls in early diagnosis of 17β-hydroxysteroid dehydrogenase deficiency: clinical, histological and molecular studies. Hormone Res 1996;46(suppl 2):93.
33. Rosler A, Kohn G: Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J Steroid Biochem 1983;19:663-74.
34. Wilson JD, Griffin JE, Russell DW: Steroid 5α-reductase 2 deficiency. Endocr Rev 1993;14:577-93.